Price & volume screen · refreshed after the Sep 28, 2026 close
Six-month momentum leaders: Healthcare
Large companies with the strongest six-month price performance. Ranks companies worth at least $1B by their six-month split-adjusted return.
| # | Company | Price | 1M | 6M | From high | Mkt cap |
|---|---|---|---|---|---|---|
| 101 | ROIVRoivant SciencesHealthcare | $36.98 | −1.6% | +39.4% | −11.6% | $26.71B |
| 102 | DXCMDexComHealthcare | $86.68 | −2.9% | +39.2% | −6.1% | $32.71B |
| 103 | AXGNAxogenHealthcare | $43.36 | −16.2% | +38.6% | −16.2% | $2.54B |
| 104 | KRYSKrystal BiotechHealthcare | $337.08 | −5.7% | +37.4% | −10.9% | $9.98B |
| 105 | VCELVericelHealthcare | $40.24 | −2.3% | +37.2% | −16.7% | $2.06B |
| 106 | PNTGThe Pennant GroupHealthcare | $40.90 | +8.1% | +37.1% | −3.7% | $1.43B |
| 107 | AVBPArriVent BioPharmaHealthcare | $29.30 | −5.5% | +36.7% | −15.7% | $1.44B |
| 108 | ALKSAlkermesHealthcare | $40.15 | −17.9% | +36.6% | −27.3% | $6.74B |
| 109 | TEVATeva Pharmaceutical Industries LimitedHealthcare | $38.88 | +3.3% | +35.3% | −3.3% | $45.35B |
| 110 | LLYEli Lilly &Healthcare | $1,184.78 | +0.7% | +34.9% | −7.5% | $1.06T |
| 111 | THCTenet Healthcare Corporation NewHealthcare | $257.93 | −3.7% | +34.4% | −8.1% | $20.77B |
| 112 | CNMDCONMEDHealthcare | $46.48 | −7.6% | +34.4% | −10.4% | $1.39B |
| 113 | LNTHLantheus HoldingsHealthcare | $99.74 | −0.7% | +33.9% | −10.1% | $6.51B |
| 114 | BTSGBrightSpring Health ServicesHealthcare | $56.54 | −7.2% | +33.6% | −22.5% | $11.19B |
| 115 | ICUIICU MedicalHealthcare | $164.03 | −6.3% | +32.1% | −12.4% | $4.10B |
| 116 | NUVBNuvation BioHealthcare | $5.60 | −19.9% | +31.8% | −41.3% | $1.97B |
| 117 | KLACKLAHealthcare | $189.17 | +2.9% | +31.1% | −37.3% | $246.87B |
| 118 | JAZZJazz PharmaceuticalsHealthcare | $238.28 | −5.1% | +30.4% | −8.9% | $15.47B |
| 119 | ANROAlto NeuroscienceHealthcare | $26.66 | −26.6% | +30.0% | −27.2% | $1.05B |
| 120 | RYTMRhythm PharmaceuticalsHealthcare | $98.56 | −12.4% | +30.0% | −16.2% | $6.79B |
| 121 | EWTXEdgewise TherapeuticsHealthcare | $39.79 | −10.0% | +29.0% | −17.7% | $4.32B |
| 122 | ARQTArcutis BiotherapeuticsHealthcare | $27.33 | +9.9% | +28.8% | −12.4% | $3.44B |
| 123 | RDNTRadNetHealthcare | $71.81 | −4.7% | +27.9% | −15.0% | $5.65B |
| 124 | SGRYSurgery PartnersHealthcare | $14.69 | +5.5% | +27.9% | −36.0% | $1.92B |
| 125 | NVAXNovavaxHealthcare | $10.80 | +19.3% | +27.8% | −3.5% | $1.78B |
| 126 | AKTSAktis OncologyHealthcare | $19.35 | −26.1% | +27.4% | −40.0% | $1.08B |
| 127 | INDVIndivior PharmaceuticalsHealthcare | $36.88 | +4.5% | +27.3% | −11.8% | $4.35B |
| 128 | ABBVABBVIEHealthcare | $266.28 | +3.1% | +27.2% | 0.0% | $470.55B |
| 129 | EHCEncompass HealthHealthcare | $124.02 | +3.7% | +27.1% | −2.5% | $12.23B |
| 130 | TRVITrevi TherapeuticsHealthcare | $14.40 | −19.8% | +27.1% | −26.2% | $2.05B |
| 131 | MMSIMerit Medical SystemsHealthcare | $87.00 | −2.8% | +26.6% | −6.6% | $5.19B |
| 132 | MDPediatrix Medical GroupHealthcare | $25.93 | −3.2% | +26.5% | −5.3% | $2.11B |
| 133 | VORVor BiopharmaHealthcare | $18.31 | −22.2% | +26.5% | −62.4% | $1.08B |
| 134 | TNGXTango TherapeuticsHealthcare | $24.30 | −3.9% | +26.2% | −26.1% | $4.10B |
| 135 | RPRXRoyalty PharmaHealthcare | $58.37 | −5.7% | +25.9% | −8.7% | $25.99B |
| 136 | JANXJanux TherapeuticsHealthcare | $16.58 | −11.7% | +25.8% | −52.3% | $1.01B |
| 137 | IDYAIDEAYA BiosciencesHealthcare | $38.22 | −8.5% | +25.5% | −10.0% | $3.69B |
| 138 | MTDMettler-Toledo InternationalHealthcare | $1,545.26 | +9.8% | +25.4% | 0.0% | $30.96B |
| 139 | VIRVir BiotechnologyHealthcare | $10.51 | −7.1% | +25.1% | −9.6% | $1.78B |
| 140 | LIVNLivaNovaHealthcare | $77.21 | −3.5% | +24.8% | −9.5% | $4.25B |
| 141 | PVLAPalvella TherapeuticsHealthcare | $139.83 | −7.0% | +24.4% | −11.6% | $2.01B |
| 142 | BIIBBiogenHealthcare | $228.69 | +3.2% | +24.4% | 0.0% | $33.79B |
| 143 | MRKMerck & Co.Healthcare | $148.69 | −0.6% | +24.3% | −5.0% | $366.84B |
| 144 | AXSMAxsome TherapeuticsHealthcare | $193.89 | −6.0% | +24.0% | −24.0% | $10.16B |
| 145 | RCUSArcus BiosciencesHealthcare | $25.01 | −18.2% | +23.3% | −20.8% | $3.18B |
| 146 | ARDTArdent HealthHealthcare | $10.47 | −4.7% | +21.9% | −31.2% | $1.48B |
| 147 | VRTXVertex PharmaceuticalsHealthcare | $527.67 | −3.6% | +21.8% | −5.4% | $133.74B |
| 148 | ACHCAcadia HealthcareHealthcare | $27.91 | −7.6% | +21.8% | −21.6% | $2.60B |
| 149 | DGXQuest DiagnosticsHealthcare | $237.62 | −2.9% | +21.5% | −4.0% | $26.23B |
| 150 | WRBYWarby ParkerHealthcare | $24.66 | −2.4% | +21.3% | −18.7% | $3.05B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.